Follow
Natalia Soriano-Sarabia
Natalia Soriano-Sarabia
Verified email at gwu.edu
Title
Cited by
Cited by
Year
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
NM Archin, JM Sung, C Garrido, N Soriano-Sarabia, DM Margolis
Nature Reviews Microbiology 12 (11), 750-764, 2014
3512014
Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T Cells
N Soriano-Sarabia, RE Bateson, NP Dahl, AM Crooks, JAD Kuruc, ...
Journal of virology 88 (24), 14070-14077, 2014
1852014
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo
C Garrido, M Abad-Fernandez, M Tuyishime, JJ Pollara, G Ferrari, ...
Journal of virology 92 (12), 10.1128/jvi. 00235-18, 2018
1162018
Prospects for treatment of latent HIV
KM Barton, BD Burch, N Soriano‐Sarabia, DM Margolis
Clinical Pharmacology & Therapeutics 93 (1), 46-56, 2013
1062013
Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
S Molina-Pinelo, A Vallejo, L Díaz, N Soriano-Sarabia, ...
Journal of antimicrobial chemotherapy 64 (3), 579-588, 2009
852009
Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression
N Soriano-Sarabia, A Vallejo, R Ramírez-Lorca, M del Mar Rodríguez, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 49 (2), 128-135, 2008
842008
Peripheral Vγ9Vδ2 T cells are a novel reservoir of latent HIV infection
N Soriano-Sarabia, NM Archin, R Bateson, NP Dahl, AM Crooks, ...
PLoS pathogens 11 (10), e1005201, 2015
742015
The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in Caucasian HIV-infected patients
I Pulido, M Leal, M Genebat, YM Pacheco, ME Sáez, N Soriano-Sarabia
Current HIV Research 8 (3), 253-258, 2010
652010
HIV latency-reversing agents have diverse effects on natural killer cell function
C Garrido, AM Spivak, N Soriano-Sarabia, MA Checkley, E Barker, ...
Frontiers in immunology 7, 209273, 2016
582016
γδ T cells: an immunotherapeutic approach for HIV cure strategies
C Garrido, ML Clohosey, CP Whitworth, M Hudgens, DM Margolis, ...
JCI insight 3 (12), 2018
312018
Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption
S Molina-Pinelo, J Vivancos, B De Felipe, N Soriano-Sarabia, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (2), 203-206, 2006
312006
Expression pattern of protease activated receptors in lymphoid cells
ML López, N Soriano-Sarabia, G Bruges, ME Marquez, KT Preissner, ...
Cellular immunology 288 (1-2), 47-52, 2014
272014
In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals
C Garrido, M Tolstrup, OS Søgaard, TA Rasmussen, B Allard, ...
Aids 33 (4), 605-613, 2019
242019
HCV RNA in peripheral blood cell subsets in HCV–HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse
B De Felipe, M Leal, N Soriano‐Sarabia, A Gutiérrez, L López‐Cortés, ...
Journal of Viral Hepatitis 16 (1), 21-27, 2009
202009
Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naive HIV-infected patients
S Molina-Pinelo, M Leal, N Soriano-Sarabia, S Gutiérrez, G Fernandez, ...
Journal of clinical virology 33 (2), 110-115, 2005
182005
Primary MHC-class II+ cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate
N Soriano-Sarabia, H Sandvold, H Jomaa, T Kubin, G Bein, H Hackstein
The Journal of Immunology 189 (11), 5212-5222, 2012
172012
High thymic volume is associated with viral replication and immunologic impairment only early after HAART interruption in chronic HIV infection
A Vallejo, A Valladares, BD Felipe, J Vivancos, S Gutierrez, ...
Viral Immunology 18 (4), 740-746, 2005
152005
Immunovirologic characteristics of human immunodeficiency virus-infected patients consisting mainly of injecting drug users on highly active antiretroviral treatment with …
A Vallejo, E Ruiz-Mateos, S Molina-Pinelo, N Soriano-Sarabia, BD Felipe, ...
Viral immunology 19 (4), 759-767, 2006
142006
HIV latency in myeloid cells: challenges for a cure
A Chitrakar, M Sanz, SB Maggirwar, N Soriano-Sarabia
Pathogens 11 (6), 611, 2022
132022
Measuring the contribution of γδ T cells to the persistent HIV reservoir
KS James, I Trumble, ML Clohosey, M Moeser, NR Roan, AA Adimora, ...
Aids 34 (3), 363-371, 2020
132020
The system can't perform the operation now. Try again later.
Articles 1–20